CTSO: CytoSorbents Corporation Company Sales Revenue

Slow approval in the US is constraining the global pricing power of Cytosorbents (CTSO), yet the company's operating revenue dynamics demonstrate resilience. The value of 0.04 represents the current level of the indicator. Stability is ensured by the integration of adsorbers into intensive care infrastructure and diversification through the application of technologies in cardiac surgery and poisoning therapy, which mitigates industry risks.

Revenue and Sales Volume: CytoSorbents Corp (CTSO) for 07/04/2022 - 11/13/2026

Comprehensive metric breakdowns and analytics for CytoSorbents Corp (CTSO)

- stock value and consensus price forecast:

Stock Quotes CytoSorbents Corp.|CTSO - Consensus Target

- market capitalization information:

Market Value CytoSorbents Corporation|CTSO - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share Cytosorbents|CTSO - Book Capitalization|Market-to-Book Ratio cytosorbents.com|CTSO - Company Total Assets

- company liabilities and liquidity data:

- company profitability and valuation multiples indicators:

CTSO - Net Income|Expected Net Income Cytosorbents|CTSO - P/E Multiple|Projected Price to Earnings Ratio CytoSorbents Corp.|CTSO - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple CytoSorbents Corporation|CTSO - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Cytosorbents|CTSO - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months cytosorbents.com|CTSO - Earnings per share growth in current year|Net earnings per share change forecast for next year Cytosorbents

- company sales and revenue statistics:

CTSO - Company Revenue|Company Future Sales Volume CytoSorbents Corp.|CTSO - P/S Multiple|Market Cap to Future Revenue Ratio CytoSorbents Corporation

Summary company analysis:CTSO cytosorbents.com

Cytosorbents occupies a strategic niche in the production of extracorporeal blood purification systems for intensive care. By analyzing the company's aggregate sales volume, an investor can track the dynamics of daily cash inflows from the sale of disposable cartridges. This metric captures the deviation of actual revenue from projected values, revealing the operational stability of the business. Regular demand for consumables ensures high margins and minimizes the risk of capital freeze.

Key competitors